Cita APA (7a ed.)
Loebstein, R., Dushinat, M., Vesterman-Landes, J., Silverman, B., Friedman, N., Katzir, I., . . . Halkin, H. (2011). Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes. Journal of Clinical Pharmacology, 51(2), 173-181.
Cita Chicago Style (17a ed.)
Loebstein, Ronen, et al. "Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes." Journal of Clinical Pharmacology 51, no. 2 (2011): 173-181.
Cita MLA (9a ed.)
Loebstein, Ronen, et al. "Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes." Journal of Clinical Pharmacology, vol. 51, no. 2, 2011, pp. 173-181.
Precaución: Estas citas no son 100% exactas.